Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Best concentration of hypertonic dextrose for knee prolotherapy in knee osteoarthritis
IRCT20201214049707N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dextrose in knee osteoarthritis (OA) (3 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Pain, Knee stiffness and 2 more. Started May 2021; status: completed.
02
Drugs
dextrose
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20201214049707N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201214049707N1.